Medicare Enrolled

Dr. Mark Weintraub, MD

Urology Physician · Bradenton, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
200 3RD AVE W, Bradenton, FL 34205
9417920340
Registered in NPPES since 2006
NPI: 1053342386 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weintraub from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weintraub? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weintraub

Dr. Mark Weintraub is an urology physician in Bradenton, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weintraub performed 3,629 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Weintraub received a total of $5,567 from 55 pharmaceutical and/or device companies across 202 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weintraub is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 30% volume in FL $5,567 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 68491 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,629
Medicare services
Top 30% in FL for urology physician
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 1,200 $2 $9
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
634 $2 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
534 $89 $320
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
526 $65 $216
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
235 $8 $60
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
90 $118 $501
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
87 $54 $418
Additional urethral implant in prostate
Placement of an additional implant into the urethra within the prostate gland using an endoscope.
50 $40 $198
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
37 $128 $431
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
34 $17 $61
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
31 $9 $132
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
24 $68 $363
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
23 $40 $121
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
21 $26 $107
Urethral implant insertion in prostate
A single implant is placed into the urethra within the prostate gland using an endoscope.
16 $150 $463
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
14 $578 $2,756
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
13 $279 $936
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
13 $138 $415
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
13 $95 $615
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
12 $25 $635
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
11 $100 $458
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
11 $25 $134
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
7.7% medium
92.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,567
Total received (2018-2024)
Avg $795/year across 7 years
Top 37% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
202
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$996
2023
$949
2022
$1,185
2021
$533
2020
$151
2019
$756
2018
$998

Payments by company (2024)

Axonics, Inc.
$269
COLOPLAST CORP
$124
Bayer Healthcare Pharmaceuticals Inc.
$105
Sumitomo Pharma America, Inc.
$73
Olympus America Inc.
$63
UROGEN PHARMA, INC.
$58
Baxter Healthcare
$45
CIVCO Medical Instruments
$40
Novartis Pharmaceuticals Corporation
$38
Janssen Biotech, Inc.
$31
Endo USA, Inc.
$27
Teleflex LLC
$24
AstraZeneca Pharmaceuticals LP
$21
Laborie Medical Technologies Corp.
$18
ABBVIE INC.
$18
Verity Pharmaceuticals Inc.
$15
BIOPROTECT MEDICAL, INC.
$15
Endo Pharmaceuticals Inc.
$14
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$1,190
KARL STORZ Endoscopy-America
$457
Janssen Biotech, Inc.
$336
Astellas Pharma US Inc
$333
Endo Pharmaceuticals Inc.
$324
Teleflex LLC
$221
Rochester Medical Corporation
$178
Medtronic USA, Inc.
$174
Wilmington Medical Supply, Inc.
$157
Biocompatibles, Inc.
$148
Sumitomo Pharma America, Inc.
$137
Bayer Healthcare Pharmaceuticals Inc.
$129
COLOPLAST CORP
$124
ROCHESTER MEDICAL CORPORATION
$120
Novartis Pharmaceuticals Corporation
$101
Janssen Products, LP
$100
Olympus America Inc.
$98
180 Medical, Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$79
Laborie Medical Technologies Corp.
$60
Verity Pharmaceuticals Inc.
$59
UROGEN PHARMA, INC.
$58
TOLMAR Pharmaceuticals, Inc.
$55
ABBVIE INC.
$54
NeoTract Inc.
$53
Ferring Pharmaceuticals Inc.
$49
PROCEPT BioRobotics Corporation
$45
Baxter Healthcare
$45
CIVCO Medical Instruments
$40
Myovant Sciences Inc.
$39
Coloplast Corp
$38
Boston Scientific Corporation
$36
Hollister Incorporated
$31
Tolmar, Inc.
$28
Janssen Scientific Affairs, LLC
$28
Endo USA, Inc.
$27
Cook Medical LLC
$27
MEDIVATION FIELD SOLUTIONS LLC
$26
Allergan Inc.
$22
GENZYME CORPORATION
$21
AstraZeneca Pharmaceuticals LP
$21
Osiris Therapeutics Inc.
$20
Antares Pharma, Inc.
$20
UROVANT SCIENCES INC
$19
PFIZER INC.
$17
AbbVie Inc.
$17
Medtronic, Inc.
$17
Retrophin, Inc.
$15
BIOPROTECT MEDICAL, INC.
$15
Amgen Inc.
$14
AngioDynamics, Inc.
$13
Myriad Genetic Laboratories, Inc.
$13
TherapeuticsMD, Inc.
$13
Blue Earth Diagnostics Limited
$12
Egalet US Inc
$11
Top 3 companies account for 35.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 8.5 FR. X 675MM · ACTIVELIFE · AFINITOR · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · BRACAnalysis CDx · CMOS VIDEO URETEROSCOPE · COOK MEDICAL EXTRACTORS · COOK MEDICAL STENTS · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENTLECATH · GRAFIX/GRAFIXPL/STRAVIX · GREENLIGHT · IMVEXXY · INTERSTIM · JELMYTO · JEVTANA · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · Prolia · RED RUBBER · ROCHESTER MAGIC3 · SELF-CATH · SPRIX · TISSEEL · TITAN · Titan · Trelstar · UROLIFT · UroLift · VISUAL-ICE · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA · iTIND System · n.a.
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in Bradenton?
Compare urology physicians in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
54
County median income
$75,792
Nearest hospital to ZIP centroid (approximate)
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weintraub is a clinical cardiology specialist, with above-average Medicare volume (top 30% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weintraub experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Weintraub performed 1,200 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Weintraub receive payments from pharmaceutical companies?
Yes. Dr. Weintraub received a total of $5,567 from 55 companies across 202 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weintraub's costs compare to other urology physicians in Bradenton?
Dr. Weintraub's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weintraub) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →